Serina Therapeutics, Inc (SER) insider trading

Every open-market stock purchase and sale by Serina Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Stephen K. Brannan (Director) bought $2K in the last 90 days.

Last 12 months: insiders bought $77.9K (5 buys) and sold $501K (25 sales). Last close $2.09 on Jul 23, 2026.

Recent SER insider trades

DateInsiderTradeValue
Jul 22, 2026Farrell Simon (Director)Bought (not open market)—
Jul 7, 2026Stephen K. Brannan (Director)Bought$2K
Jun 17, 2026Gregory Bailey (Director)Bought (not open market)$15M
Jun 17, 2026Gregory Bailey (Director)Bought (not open market)$4M
Jun 17, 2026Gregory Bailey (Director)Bought (not open market)$1.7M
Jun 17, 2026Jay Venkatesan (Director)Bought (not open market)$504K
Jun 17, 2026Jay Venkatesan (Director)Bought (not open market)$217K
Jun 17, 2026Gregory Bailey (Director)Bought (not open market)—
Jun 17, 2026Stephen K. Brannan (Director)Bought (not open market)—
Jun 17, 2026Gregory Bailey (Director)Bought (not open market)—
Jun 17, 2026Richard Peter Marshall (Director)Bought (not open market)—
Jun 17, 2026Jay Venkatesan (Director)Bought (not open market)—
Jun 17, 2026Karen J Wilson (Director)Bought (not open market)—
Jun 12, 2026Karen J Wilson (Director)Bought$8.8K
Jun 11, 2026Karen J Wilson (Director)Bought$8.9K
May 26, 2026Steven A Ledger (CEO)Bought (not open market)$19.5K
May 22, 2026Karen J Wilson (Director)Bought$19.3K
May 22, 2026Jay Venkatesan (Director)Bought$1K
May 21, 2026Karen J Wilson (Director)Bought$17.7K
May 21, 2026Steven A Ledger (CEO)Bought (not open market)—
May 21, 2026Randall Moreadith (C-suite exec)Bought (not open market)—
May 21, 2026Srini Tenjarla (VP)Bought (not open market)—
May 21, 2026Gregory S Curhan (CFO)Bought (not open market)—
May 19, 2026Richard Peter Marshall (Director)Bought$20.1K
Mar 31, 2026Gregory Bailey (Director)Bought (not open market)$116K

Who's trading SER

Get free alerts when an insider at Serina Therapeutics, Inc files a new trade →